Dr. Maithreyi Sarma, MD

Dr. Sarma practices at Mary Washington Hospital in Fredericksburg, Virginia, part of Mary Washington Healthcare.

Dr. Sarma's NPI, 1831631647, was assigned on November 9, 2016. Dr. Sarma holds Virginia license 0101273932.

Dr. Sarma's primary practice is Mary Washington Hospital, at 1001 Sam Perry Boulevard, Fredericksburg, VA 22401 in Fredericksburg City. The practice phone is (540) 741-1100.

Dr. Sarma's primary practice is Mary Washington Hospital in Fredericksburg, Virginia, part of Mary Washington Healthcare. Dr. Sarma is also affiliated with Stafford Hospital. The medical group on file is Mary Washington Healthcare. Dmand AI also links Dr. Sarma to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sarma practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sarma's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Sarma's licenses on file in 2 states: Virginia and District of Columbia.

CMS data shows 895 Medicare services from Dr. Sarma across 11 procedure codes in 2024, for 260 Medicare patients. Medicare paid $65,346 for them. Every service was in an office.

CMS counts 260 Medicare patients who saw Dr. Sarma in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sarma's median patient age at 68, with 82% women.

In 2024, Dr. Sarma wrote 359 Medicare Part D claims for 95 patients. 74% of them were for generic drugs. CMS names the drug for 222 of them, across 5 drugs with 11 or more claims each, at $67,446 in total drug cost. In 2023, CMS named 82 claims across 4 drugs.

Dr. Sarma accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Sarma, published from 2020 to 2022. 2020 was the busiest year, with 2. Dr. Sarma's most frequent co-authors are Shipra Gandhi, MBBS, Ajay Dhakal, MBBS and Amy P. Early, MD.

CMS Open Payments shows 27 general payments to Dr. Sarma from 14 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 80% of the total. Merck Sharp & Dohme Corporation paid the most, $131.